1.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Temporarily closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: JHOC-J0658, CDR0000504083, U01CA070095, P30CA006973, JHOC-J0658, J0658, 7759, NCT00387465
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SNDX-275-0401, NCT00602030
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000540608, U01CA070095, P30CA006973, JHOC-J06114, J06114, 7605, NA_00006989, NCT00462605
|
|
4.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SNDX-275-0301, NCT00676663
|
|
5.
|
Phase: Phase II Type: Treatment Status: Completed Age: Over 18 Sponsor: Pharmaceutical / Industry Protocol IDs: SNDX-275-0403, NCT00750698
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: Postmenopausal Sponsor: Pharmaceutical / Industry Protocol IDs: SNDX-275-0303, NCT00828854
|
|
7.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SNDX-275-0501, NCT00866333
|
|
8.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MAYO-MC084B, MC084B, 8341, NCT01105377
|
|
9.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: JHOC-J0438, 6798, NCI-6798, JHOC-04060103, NCT00098891
|
|
10.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000405841, J0443, U01CA070095, P30CA006973, JHOC-J0443, NCI-6591, JHOC-04061109, 6591, NCT00101179
|
|
11.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Temporarily closed Age: 18 and over Sponsor: NCI Protocol IDs: RPCI-I-165409, I-165409, 8272, NCT01159301
|
|
12.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, NIH WGMCC Protocol IDs: 010124, 01-C-0124, NCI-2792, CDR0000068615, NCI-01-C-0124, 2792, NCT00020579
|